BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31229879)

  • 1. Conditional Deletion of Eaf1 Induces Murine Prostatic Intraepithelial Neoplasia in Mice.
    Pascal LE; Su F; Wang D; Ai J; Song Q; Wang Y; O'Malley KJ; Cross B; Rigatti LH; Green A; Dhir R; Wang Z
    Neoplasia; 2019 Aug; 21(8):752-764. PubMed ID: 31229879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. U19/Eaf2 knockout causes lung adenocarcinoma, B-cell lymphoma, hepatocellular carcinoma and prostatic intraepithelial neoplasia.
    Xiao W; Zhang Q; Habermacher G; Yang X; Zhang AY; Cai X; Hahn J; Liu J; Pins M; Doglio L; Dhir R; Gingrich J; Wang Z
    Oncogene; 2008 Mar; 27(11):1536-44. PubMed ID: 17873910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a reactive stroma associated with prostatic intraepithelial neoplasia in EAF2 deficient mice.
    Pascal LE; Ai J; Masoodi KZ; Wang Y; Wang D; Eisermann K; Rigatti LH; O'Malley KJ; Ma HM; Wang X; Dar JA; Parwani AV; Simons BW; Ittman MM; Li L; Davies BJ; Wang Z
    PLoS One; 2013; 8(11):e79542. PubMed ID: 24260246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant loss of EAF2/U19 and Pten synergistically promotes prostate carcinogenesis in the mouse model.
    Ai J; Pascal LE; O'Malley KJ; Dar JA; Isharwal S; Qiao Z; Ren B; Rigatti LH; Dhir R; Xiao W; Nelson JB; Wang Z
    Oncogene; 2014 May; 33(18):2286-94. PubMed ID: 23708662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EAF2 loss enhances angiogenic effects of Von Hippel-Lindau heterozygosity on the murine liver and prostate.
    Pascal LE; Ai J; Rigatti LH; Lipton AK; Xiao W; Gnarra JR; Wang Z
    Angiogenesis; 2011 Sep; 14(3):331-43. PubMed ID: 21638067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent EAF2 and ELL2 loss phenocopies individual EAF2 or ELL2 loss in prostate cancer cells and murine prostate.
    Zhong M; Pascal LE; Cheng E; Masoodi KZ; Chen W; Green A; Cross BW; Parrinello E; Rigatti LH; Wang Z
    Am J Clin Exp Urol; 2018; 6(6):234-244. PubMed ID: 30697579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conditional deletion of ELL2 induces murine prostate intraepithelial neoplasia.
    Pascal LE; Masoodi KZ; Liu J; Qiu X; Song Q; Wang Y; Zang Y; Yang T; Wang Y; Rigatti LH; Chandran U; Colli LM; Vencio RZN; Lu Y; Zhang J; Wang Z
    J Endocrinol; 2017 Nov; 235(2):123-136. PubMed ID: 28870994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EAF2 loss induces prostatic intraepithelial neoplasia from luminal epithelial cells in mice.
    Pascal LE; Rigatti LH; Ai J; Zhang A; Zhou J; Nelson JB; Wang Z
    Am J Clin Exp Urol; 2020; 8(1):18-27. PubMed ID: 32211450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined Loss of EAF2 and p53 Induces Prostate Carcinogenesis in Male Mice.
    Wang Y; Pascal LE; Zhong M; Ai J; Wang D; Jing Y; Pilch J; Song Q; Rigatti LH; Graham LE; Nelson JB; Parwani AV; Wang Z
    Endocrinology; 2017 Dec; 158(12):4189-4205. PubMed ID: 29029019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ELL-associated factor 2 (EAF2), a functional homolog of EAF1 with alternative ELL binding properties.
    Simone F; Luo RT; Polak PE; Kaberlein JJ; Thirman MJ
    Blood; 2003 Mar; 101(6):2355-62. PubMed ID: 12446457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EAF2 regulates DNA repair through Ku70/Ku80 in the prostate.
    Ai J; Pascal LE; Wei L; Zang Y; Zhou Y; Yu X; Gong Y; Nakajima S; Nelson JB; Levine AS; Lan L; Wang Z
    Oncogene; 2017 Apr; 36(15):2054-2065. PubMed ID: 27721405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EAF2 and p53 Co-Regulate STAT3 Activation in Prostate Cancer.
    Pascal LE; Wang Y; Zhong M; Wang D; Chakka AB; Yang Z; Li F; Song Q; Rigatti LH; Chaparala S; Chandran U; Parwani AV; Wang Z
    Neoplasia; 2018 Apr; 20(4):351-363. PubMed ID: 29518696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Klf5 deletion promotes Pten deletion-initiated luminal-type mouse prostate tumors through multiple oncogenic signaling pathways.
    Xing C; Ci X; Sun X; Fu X; Zhang Z; Dong EN; Hao ZZ; Dong JT
    Neoplasia; 2014 Nov; 16(11):883-99. PubMed ID: 25425963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of the p16INK4a tumor suppressor and expression of the androgen receptor induce sarcomatoid carcinomas with signet ring cells in the mouse prostate.
    Lee DH; Yu EJ; Aldahl J; Yang J; He Y; Hooker E; Le V; Mi J; Olson A; Wu H; Geradts J; Xiao GQ; Gonzalgo ML; Cardiff RD; Sun Z
    PLoS One; 2019; 14(1):e0211153. PubMed ID: 30677079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ETV4 promotes late development of prostatic intraepithelial neoplasia and cell proliferation through direct and p53-mediated downregulation of p21.
    Cosi I; Pellecchia A; De Lorenzo E; Torre E; Sica M; Nesi G; Notaro R; De Angioletti M
    J Hematol Oncol; 2020 Aug; 13(1):112. PubMed ID: 32791988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conditional deletion of the Pten gene in the mouse prostate induces prostatic intraepithelial neoplasms at early ages but a slow progression to prostate tumors.
    Kwak MK; Johnson DT; Zhu C; Lee SH; Ye DW; Luong R; Sun Z
    PLoS One; 2013; 8(1):e53476. PubMed ID: 23308230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pace of prostatic intraepithelial neoplasia development is determined by the timing of Pten tumor suppressor gene excision.
    Luchman HA; Benediktsson H; Villemaire ML; Peterson AC; Jirik FR
    PLoS One; 2008; 3(12):e3940. PubMed ID: 19081794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of survivin in the prostate epithelium impedes carcinogenesis in a mouse model of prostate adenocarcinoma.
    Adisetiyo H; Liang M; Liao CP; Aycock-Williams A; Cohen MB; Xu S; Neamati N; Conway EM; Cheng CY; Nikitin AY; Roy-Burman P
    PLoS One; 2013; 8(7):e69484. PubMed ID: 23936028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of atbf1/zfhx3 in mouse prostate causes neoplastic lesions, likely by attenuation of membrane and secretory proteins and multiple signaling pathways.
    Sun X; Fu X; Li J; Xing C; Frierson HF; Wu H; Ding X; Ju T; Cummings RD; Dong JT
    Neoplasia; 2014 May; 16(5):377-89. PubMed ID: 24934715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additive Effect of Zfhx3/Atbf1 and Pten Deletion on Mouse Prostatic Tumorigenesis.
    Sun X; Xing C; Fu X; Li J; Zhang B; Frierson HF; Dong JT
    J Genet Genomics; 2015 Jul; 42(7):373-82. PubMed ID: 26233892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.